DarioHealth (DRIO)

The company is distinctive because it is not limited to a software interface. DarioHealth integrates FDA-cleared connected hardware, mobile applications, real-time data capture, and behavioural support into a single user experience. This structure allows the platform to collect physiological and engagement data directly from members and use those insights to tailor interventions, reminders, coaching, and care pathways.

DarioHealth serves employers, health plans, providers, and other healthcare partners that want scalable tools to support people living with chronic conditions. Its model is built around improving engagement and outcomes while helping payers and organisations address the cost burden associated with long-term disease management. The company positions its health intelligence platform as a way to encourage sustained behaviour change, which is often one of the hardest parts of managing chronic illness.

The broader market for DarioHealth includes digital therapeutics, remote patient monitoring, virtual care, and population health management. Demand in these areas is driven by rising chronic disease prevalence, pressure to lower healthcare costs, and the increasing acceptance of app-based and connected-care tools. For investors, DRIO represents exposure to a healthcare technology company seeking to combine consumer-friendly digital experiences with clinically oriented data and personalised support.